FDA Inspection 1258639 — Private Label Partners, Inc.

Private Label Partners, Inc. — FEI 3003350069

The FDA completed an inspection of Private Label Partners, Inc. on January 17, 2025 in Santa Ana, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 17, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
183321 CFR 211.84(d)(1)Identity Testing of Each Component
184321 CFR 211.84(d)(2)Component written specification
188321 CFR 211.165(a)Testing and release for distribution
191221 CFR 211.166(a)Written program not followed
200921 CFR 211.188Prepared for each batch, include complete information
202721 CFR 211.192Investigations of discrepancies, failures
360321 CFR 211.160(b)Scientifically sound laboratory controls